Guidance

vCJD and transfusion of blood components: updated risk assessment

Paper on the transmission of variant vCJD from person to person though receipt of donated blood components.

• From: Department of Health and Social Care
• Published: 15 April 2013

This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Applies to England

Documents

vCJD and transfusion of blood components: an updated risk assessment

PDF, 503 KB, 38 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Annexes to vCJD and transfusion of blood components: an updated risk assessment

PDF, 449 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This risk assessment presents a mathematical model, primarily designed to examine how many future clinical cases might be caused in this way.

Key inputs to the model include the number of donors that might be carrying Creutzfeldt-Jakob Disease (vCJD) infection without showing any symptoms, the infective dose in blood components sourced from such a donor and the likelihood of recipients surviving long enough to develop symptoms of vCJD if infected.

Published 15 April 2013